In the last few years, a variety of experimental and clinical studies concerning the formation,
metabolism, and cellular effects of cholesterol oxidation products (COPs) have been carried
out. Nevertheless, a substantial lack of knowledge exists regarding the possible intake of
these compounds by the newborn through human and/or adapted formula milk. As far as the
pathological role of COPs is concerned, exhaustive studies have shown that since dietary
COPs are cytotoxic and atherotoxic, they may lead to adverse effects on health. The aim of …